Format

Send to

Choose Destination

See 1 citation found using an alternative search:

Int J Cardiol. 2015 Apr 1;184:428-30. doi: 10.1016/j.ijcard.2015.02.077. Epub 2015 Feb 24.

Chronic kidney disease has a significant impact on platelet inhibition of new P2Y12 inhibitors.

Author information

1
Département de Cardiologie, CHU Timone, Marseille F-13385, France; INSERM, UMR1062, Nutrition, Obesity and Risk of Thrombosis, F-13385 Marseille, France; Aix-Marseille Université, Faculté de Médecine, F-13385 Marseille, France.
2
Département de Cardiologie, CHU Timone, Marseille F-13385, France; Aix-Marseille Université, Faculté de Médecine, F-13385 Marseille, France.
3
Assistance Publique-Hôpitaux de Marseille, Equipe Mobile d'Aide à l'Investigation (EMAI), France.
4
INSERM, UMR1062, Nutrition, Obesity and Risk of Thrombosis, F-13385 Marseille, France; Aix-Marseille Université, Faculté de Médecine, F-13385 Marseille, France; Laboratoire d'Hématologie, CHU Timone, Marseille F-13385, France.
5
Département de Cardiologie, CHU Timone, Marseille F-13385, France; INSERM, UMR1062, Nutrition, Obesity and Risk of Thrombosis, F-13385 Marseille, France; Aix-Marseille Université, Faculté de Médecine, F-13385 Marseille, France. Electronic address: thomas.cuisset@ap-hm.fr.

KEYWORDS:

Acute coronary syndromes; Chronic kidney disease; Keywords; P2Y12 blockers; Platelet reactivity

PMID:
25755059
DOI:
10.1016/j.ijcard.2015.02.077
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center